🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be conducted to evaluate the efficacy of lecanemab in parti...
Status
Active Not Recruiting
Location
Banner Alzheimer's Institute- Clinical Trials Department
Start Date
2019-03-27
Trial ID
NCT03887455
Treatments Being Tested
This study will evaluate the percentage change from baseline in weight afte...
Status
Completed
Location
Handan First Hospital
Start Date
2024-08-14
Trial ID
NCT07020884
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of mirikiz...
Status
Completed
Location
Univ of Connecticut
Start Date
2018-04-24
Trial ID
NCT03482011
Treatments Being Tested
This randomized, double-blind, placebo-controlled, parallel-group study wil...
Status
Terminated
Location
Imaging End Points Clinical Research
Start Date
2017-03-29
Trial ID
NCT03114657
Treatments Being Tested
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of guselkumab...
Status
Completed
Location
Rheumatology Associates
Start Date
2017-07-12
Trial ID
NCT03158285
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of ixekizumab do...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2015-08
Trial ID
NCT02513550
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of fasinumab...
Status
Terminated
Location
Regeneron Research Site
Start Date
2017-10-30
Trial ID
NCT03285646
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 392028
Start Date
2015-11-30
Trial ID
NCT02584504
Treatments Being Tested